心率变化作为危重儿童急性灾难性脑损伤脑死亡潜在数字生物标志物
本研究为单中心回顾性研究(2008-2020年),纳入96例急性灾难性脑损伤危重患儿,用每5秒采样的心率数值计算心率变化(HRC,5分钟窗口、50%重叠、死亡或记录结束前最长5天)。死亡前24小时内,脑死亡组HRC为0.01,低于心源性死亡组的0.03和存活组的0.04(p=0.001);脑死亡组HRC在死亡前至少1天即开始下降。HRC区分脑死亡与心源性死亡及存活者的敏感性90%、特异性70%、阳性预测值44%、阴性预测值96%,受试者工作特征曲线下面积0.88(95%CI 0.80-0.93)。作者认为HRC是一种新型数字生物标志物,经进一步验证后可能有助于在灾难性脑损伤患者整体病程中分类脑死亡。
要点
- 死亡前24小时内,脑死亡组HRC为0.01,低于心源性死亡组的0.03和存活组的0.04(p=0.001)。
- 脑死亡组HRC在死亡前至少1天即出现下降。
- HRC区分脑死亡与心源性死亡及存活者:敏感性90%、特异性70%、阳性预测值44%、阴性预测值96%。
- 受试者工作特征曲线下面积0.88(95%CI 0.80-0.93)。
- 作者认为HRC经进一步验证后可能作为灾难性脑损伤患者脑死亡的分类工具。
适用人群与场景
- 单中心2008-2020年收治的急性灾难性脑损伤危重患儿;均接受神经重症会诊、入住ICU、就诊时或住院期间基于临床和/或影像学存在急性神经损伤,且死亡或出院时格拉斯哥昏迷评分小于13分。
诊断标准与关键阈值
- 脑死亡组为符合脑死亡标准的患者;心源性死亡组为心肺死亡患者;存活组为存活至出院者。
- HRC计算:每5秒采样的心率数值,以5分钟窗口、50%重叠,计算心率四分位距除以中位心率,取死亡或记录结束前最长5天。
研究设计与关键结果
- 96例灾难性脑损伤患儿中69%为男性,中位年龄4岁;28例死亡(脑死亡8例、心源性死亡20例),20例存活(出院时中位格拉斯哥昏迷评分9分)。
- 死亡前24小时内,脑死亡组HRC为0.01,心源性死亡组为0.03,存活组为0.04(p=0.001)。
- 脑死亡组HRC在死亡前至少1天即下降。
- HRC区分脑死亡与心源性死亡及存活者:敏感性90%、特异性70%、阳性预测值44%、阴性预测值96%,受试者工作特征曲线下面积0.88(95%CI 0.80-0.93)。
证据类型、等级与局限
- 单中心、回顾性研究(2008-2020年)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为HRC是一种新型数字生物标志物,经进一步验证后可能有助于在灾难性脑损伤患者整体病程中对脑死亡进行分类。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
UNLABELLED: Bedside measurement of heart rate (HR) change (HRC) may provide an objective physiologic marker for when brain death (BD) may have occurred, and BD testing is indicated in children.
OBJECTIVES: To determine whether HRC, calculated using numeric HR measurements sampled every 5 seconds, can identify patients with BD among patients with catastrophic brain injury (CBI).
DESIGN SETTING AND PARTICIPANTS: Single-center, retrospective study (2008-2020) of critically ill children with acute CBI. Patients with CBI had a neurocritical care consultation, were admitted to an ICU, had acute neurologic injury on presentation or during hospitalization based on clinical and/or imaging findings, and died or survived with Glasgow Coma Scale (GCS) less than 13 at hospital discharge. Patients meeting BD criteria (BD group) were compared with those with cardiopulmonary death (CD group) or those who survived to discharge.
MAIN OUTCOMES AND MEASURES: HRC was calculated as the interquartile range of HR divided by median HR using 5-minute windows with 50% overlap for up to 5 days before death or end of recording. HRC was compared among the BD, CD, and survivor groups.
RESULTS: Of 96 patients with CBI (69% male, median age 4 years), 28 died (8 BD, 20 CD) and 20 survived (median GCS 9 at discharge). Within 24 hours before death, HRC was lower in BD compared with CD patients or survivors (0.01 vs 0.03 vs 0.04, p = 0.001). In BD patients, HRC decreased at least 1 day before death. HRC discriminated BD from CD patients and survivors with 90% sensitivity, 70% specificity, 44% positive predictive value, 96% negative predictive value (area under the receiver operating characteristic curve 0.88, 95% CI, 0.80-0.93).
CONCLUSIONS AND RELEVANCE: HRC is a novel digital biomarker that, with further validation, may be useful as a classifier for BD in the overall course of patients with CBI.
参考来源
- LaRovere KL, Luchette M, Akhondi-Asl A, et al. Heart Rate Change as a Potential Digital Biomarker of Brain Death in Critically Ill Children With Acute Catastrophic Brain Injury. Crit Care Explor. 2023. PMID: 37151893. doi:10.1097/CCE.0000000000000908
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。